{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:43:00Z","timestamp":1793292180129,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023JH2\/20200120"],"award-info":[{"award-number":["2023JH2\/20200120"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200971"],"award-info":[{"award-number":["82200971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023MD744267"],"award-info":[{"award-number":["2023MD744267"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116701","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:41:31Z","timestamp":1715312491000},"page":"116701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"175","author":[{"given":"Jingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8880-9984","authenticated-orcid":false,"given":"Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116701_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111531","article-title":"Sleeve gastrectomy suppresses hepatic de novo cholesterogenesis and improves hepatic cholesterol accumulation in obese rats with type 2 diabetes mellitus","volume":"94","author":"Chen","year":"2022","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2024.116701_bib3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2023-329998","article-title":"Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD","volume":"72","author":"Marjot","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2024.116701_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116701_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116701_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1113\/JP280908","article-title":"NAD+ and NAFLD - caution, causality and careful optimism","volume":"600","author":"Dall","year":"2022","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116701_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing.","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.biopha.2024.116701_bib9","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/bph.13513","article-title":"Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing","volume":"173","author":"Zhou","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116701_bib10","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1210\/jc.2009-2148","article-title":"Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease","volume":"95","author":"Dahl","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.biopha.2024.116701_bib11","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.3390\/nu14153231","article-title":"Supplementation with NAD(+) and its precursors to prevent cognitive decline across disease contexts.","volume":"14","author":"Campbell","year":"2022","journal-title":"Nutrients"},{"issue":"Suppl 3(0 3)","key":"10.1016\/j.biopha.2024.116701_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/dom.12171","article-title":"The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing","volume":"15","author":"Imai","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD(+) Intermediates: the biology and therapeutic potential of NMN and NR.","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biopha.2024.116701_bib15","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.celrep.2016.07.027","article-title":"NAMPT-Mediated NAD(+) biosynthesis in adipocytes regulates adipose tissue function and multi-organ insulin sensitivity in mice","volume":"16","author":"Stromsdorfer","year":"2016","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.biopha.2024.116701_bib16","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2024.116701_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Cant\u00f3","year":"2012","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.biopha.2024.116701_bib19","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.3390\/ijms20184359","article-title":"Combined Treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis","volume":"20","author":"Salic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116701_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep26933","article-title":"Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice","volume":"6","author":"Trammell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116701_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2019.03.064","article-title":"Nicotinamide riboside protects against liver fibrosis induced by CCl(4) via regulating the acetylation of Smads signaling pathway.","volume":"225","author":"Jiang","year":"2019","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116701_bib22","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bbadis.2019.06.009","article-title":"Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis","volume":"1865","author":"Lee","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"12_suppl","key":"10.1016\/j.biopha.2024.116701_bib23","doi-asserted-by":"crossref","first-page":"S666","DOI":"10.1177\/09603271211052991","article-title":"NAMPT-mediated NAD+biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice","volume":"40","author":"Xu","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.biopha.2024.116701_bib24","article-title":"Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE 2 degradation","author":"ZZ","year":"2020","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116701_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102766","article-title":"A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility","volume":"55","author":"Wei","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cbpc.2005.07.009","article-title":"mRNA expression of antioxidant enzymes (SOD, CAT and GSH-Px) and lipid peroxidative stress in liver of Atlantic salmon (Salmo salar) exposed to hyperoxic water during smoltification","volume":"141","author":"Olsvik","year":"2005","journal-title":"Comp. Biochem Physiol. C. Toxicol. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116701_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/antiox9070578","article-title":"Serum malondialdehyde is associated with non-alcoholic fatty liver and related liver damage differentially in men and women","volume":"9","author":"Zelber-Sagi","year":"2020","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.biopha.2024.116701_bib29","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bbadis.2019.06.009","article-title":"Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis","volume":"1865","author":"Pham","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116701_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1476-511X-13-197","article-title":"Protective effect of arachidonic acid and linoleic acid on 1-methyl-4-phenylpyridinium-induced toxicity in PC12 cells","volume":"13","author":"Tang","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.116701_bib31","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/db16-1519","article-title":"Acyl-CoA Thioesterase 1 (ACOT1) regulates PPAR\u03b1 to couple fatty acid flux with oxidative capacity during fasting","volume":"66","author":"Franklin","year":"2017","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(00)00345-2","article-title":"16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes","volume":"60","author":"Bednar","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116701_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD(+) in regulating cellular and metabolic signaling pathways.","volume":"49","author":"Amjad","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2024.116701_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1021\/acs.jproteome.8b00945","article-title":"Metabolic and gut microbial characterization of obesity-prone mice under a high-fat diet","volume":"18","author":"Gu","year":"2019","journal-title":"J. Proteome Res."},{"issue":"13","key":"10.1016\/j.biopha.2024.116701_bib36","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3390\/nu15133064","article-title":"Defining NAD(P)(H) Catabolism","volume":"15","author":"Dhuguru","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.biopha.2024.116701_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202113943","article-title":"Houtkooper RH. NAD(+) homeostasis in human health and disease","volume":"13","author":"Zapata-P\u00e9rez","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116701_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ajcn\/nqy132","article-title":"A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects","volume":"108","author":"Dollerup","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2024.116701_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ajcn\/nqaa072","article-title":"Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans","volume":"112","author":"Remie","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2024.116701_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120051","article-title":"Amelioration of hydrolyzed guar gum on high-fat diet-induced obesity: integrated hepatic transcriptome and metabolome","volume":"297","author":"Fu","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2024.116701_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116701_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.fct.2017.02.039","article-title":"Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL\/6J female mice: role of disturbed lipid homeostasis and increased oxidative stress","volume":"103","author":"Choi","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cells9040791","article-title":"Administration of nicotinamide mononucleotide (NMN) reduces metabolic impairment in male mouse offspring from obese mothers","volume":"9","author":"Uddin","year":"2020","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.biopha.2024.116701_bib44","doi-asserted-by":"crossref","first-page":"14050","DOI":"10.1074\/jbc.M109.001107","article-title":"Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice","volume":"284","author":"Hui","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116701_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17195-y","article-title":"The major urinary protein gene cluster knockout mouse as a novel model for translational metabolism research","volume":"12","author":"Greve","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116701_bib46","article-title":"Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation","author":"Zong JL","year":"2021","journal-title":"Free Radic. Biol. \u2026"},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13695","article-title":"Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis","volume":"52","author":"Guerra","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.biopha.2024.116701_bib48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","year":"2015","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib49","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-009-1282-2","article-title":"Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib50","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/cas.13529","article-title":"Stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells","volume":"109","author":"Shibasaki","year":"2018","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116701_bib51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116701_bib52","article-title":"Dietary linoleic acid and the ratio of unsaturated to saturated fatty acids are inversely associated with significant liver fibrosis risk: a nationwide survey","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Nutr."},{"issue":"11","key":"10.1016\/j.biopha.2024.116701_bib53","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"624","key":"10.1016\/j.biopha.2024.116701_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg8117","article-title":"Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116701_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MNH.0000000000000088","article-title":"Cytochrome P450 eicosanoids in hypertension and renal disease","volume":"24","author":"Fan","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2024.116701_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108484","article-title":"Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies","volume":"86","author":"Hildreth","year":"2020","journal-title":"J. Nutr. Biochem"},{"key":"10.1016\/j.biopha.2024.116701_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120229","article-title":"12,13-diHOME as a new therapeutic target for metabolic diseases","volume":"290","author":"Mac\u00eado","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116701_bib58","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab. Dispos."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:39:09Z","timestamp":1741030749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224005857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":58,"alternative-id":["S0753332224005857"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116701","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116701"}}